Anticoagulation in High Bleeding Risk Cancer Patients - Dr Nolukholo Ncete
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only! Grab it Learn about managing anticoagulation in cancer patients with high bleeding risk in this comprehensive lecture. Explore therapeutic options for cancer-associated thrombosis (CAT), examining evidence for various drugs. Delve into conditions that increase bleeding risk in CAT patients on anticoagulation. Discover monitoring techniques for anticoagulants and review a treatment algorithm based on platelet count. Cover topics including incidental VTEs, cancer-associated risk factors, LMWH versus VKA and DOACs, considerations for prescribing DOACs, thrombocytopenia, renal and hepatic impairment, use of antiplatelet agents, and special patient populations. Gain insights on IVC filters, mechanical prophylaxis, DOAC testing, LMWH monitoring, and warfarin initiation.